Treacher Collins Syndrome (TCS) is a rare genetic disorder characterized by craniofacial abnormalities that affect the development of the bones and tissues of the face. The condition varies widely in severity, but it typically involves underdeveloped facial bones, especially the cheekbones and jaw, leading to distinctive facial features. TCS does not typically affect intelligence, and affected individuals usually have normal cognitive development. However, severe facial abnormalities can make breathing and swallowing difficult and may require surgery. It can also affect other senses, such as eyesight and hearing, due to malformations in the bones and tissues surrounding the eyes and ears.
Treacher Collins Syndrome (TCS) is a rare genetic disorder characterized by craniofacial abnormalities that affect the development of the bones and tissues of the face. The condition varies widely in severity, but it typically involves underdeveloped facial bones, especially the cheekbones and jaw, leading to distinctive facial features. TCS does not typically affect intelligence, and affected individuals usually have normal cognitive development. However, severe facial abnormalities can make breathing and swallowing difficult and may require surgery. It can also affect other senses, such as eyesight and hearing, due to malformations in the bones and tissues surrounding the eyes and ears.
Treacher Collins Syndrome is rare, with an estimated prevalence of about 1 in 50,000 live births. It affects both children born genetically male and female equally and has been reported in various ethnic groups worldwide.
Name | Abbreviation |
---|---|
Mandibulofacial Dysostosis | |
Franceschetti-Zwahlen-Klein Syndrome | |
Treacher Collins-Franceschetti Syndrome |
TCS is primarily caused by mutations in the TCOF1, POLR1C, or POLR1D genes. These genes play crucial roles in the early development of facial bones and tissues. Most cases (approximately 90-95%) are due to mutations in the TCOF1 gene, which encodes a protein involved in the production of ribosomal RNA, essential for cell growth and proliferation. The mutations disrupt the normal development of the facial bones and other structures during embryonic development. TCS is inherited in an autosomal dominant pattern, meaning that only one copy of the mutated gene is needed to cause the disorder (see RareShare Guide on Genetic Inheritance). However, some cases result from new (de novo) mutations, occurring in individuals with no family history of the condition.
The symptoms of Treacher Collins Syndrome are primarily related to craniofacial abnormalities:
Facial Features: Individuals with TCS often have underdeveloped cheekbones (zygomatic bones), a small jaw and chin (micrognathia), downward-slanting eyes, and a notched lower eyelid (coloboma). The ears may be small, malformed, or absent, leading to hearing loss.
Hearing Loss: Conductive hearing loss is common due to abnormalities in the structures of the middle ear, which can affect the ability to transmit sound.
Airway and Breathing Problems: A small jaw and other craniofacial abnormalities can lead to airway obstruction, making breathing difficult, particularly during sleep (sleep apnea).
Dental Issues: Dental anomalies such as misaligned teeth or missing teeth are common due to the abnormal development of the jaw and palate.
Diagnosis of Treacher Collins Syndrome is typically based on the characteristic physical features and a thorough medical history. A clinical evaluation by a specialist in craniofacial disorders is essential for accurate diagnosis. Genetic testing can confirm the diagnosis by identifying mutations in the TCOF1, POLR1C, or POLR1D genes.
Genetic Testing: Sequencing of the TCOF1, POLR1C, or POLR1D genes is used to confirm the diagnosis of TCS by detecting the specific mutations responsible for the disorder.
Imaging Studies: X-rays, CT scans, or MRIs of the skull and facial bones may be used to assess the extent of bone abnormalities.
Hearing Tests: Audiometric tests are used to evaluate the extent of hearing loss and to plan appropriate interventions.
Treatment for Treacher Collins Syndrome is tailored to the individual's specific symptoms and needs, often requiring a multidisciplinary approach:
Surgical Interventions: Multiple surgeries may be needed to correct facial abnormalities, improve breathing, and address hearing issues. Common procedures include reconstructive surgery for the cheekbones and jaw, ear reconstruction, and cleft palate repair.
Hearing Aids: Hearing aids or bone-anchored hearing systems may be used to manage conductive hearing loss.
Speech Therapy: Individuals with TCS may require speech therapy to address speech and language difficulties related to hearing loss or cleft palate.
Orthodontic Treatment: Orthodontic interventions, including braces or dental surgery, are often needed to address dental anomalies.
The prognosis for individuals with Treacher Collins Syndrome is generally good, especially with appropriate medical and surgical management. While TCS can present significant challenges, particularly related to breathing, hearing, and appearance, most individuals lead normal, healthy lives. Intelligence and cognitive development are typically unaffected, and with early intervention, many of the functional impairments associated with TCS can be mitigated.
https://medlineplus.gov/genetics/condition/treacher-collins-syndrome/
Dixon, J., & Dixon, M. J. (2004). "Treacher Collins syndrome." Orthodontics & Craniofacial Research, 7(3), 159-169.
Trainor, P. A., & Andrews, B. T. (2013). "Facial dysostoses: Etiology, pathogenesis and management." American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 163(4), 283-294.
Marres, H. A. (1996). "Treacher Collins syndrome: A clinical, radiological, and genetic linkage study in three families." International Journal of Pediatric Otorhinolaryngology, 35(1), 35-47.
Splendore, A., Silva, E. O., & Alonso, L. G. (2005). "High mutation detection rate in TCOF1 among Treacher Collins syndrome patients reveals clustering of mutations in the treacle gene." Human Mutation, 26(4), 290-296.
There are no new discussions. Start one now!!
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.
Enrolling is easy.
After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.
Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.
Visit sanfordresearch.org/CoRDS to enroll.
Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.
Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.
There are no new discussions. Start one now!!
Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.
FIND YOUR COMMUNITYOur rare disease resources include e-books and podcasts
Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.